- Home
- BGLC vs CEAD Comparison
BGLC vs CEAD Comparison
Compare BGLC & CEAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BGLC
- CEAD
- Stock Information
- Founded
- BGLC 2017
- CEAD 2009
- Country
- BGLC Malaysia
- CEAD United States
- Employees
- BGLC N/A
- CEAD N/A
- Industry
- BGLC Medical Specialities
- CEAD Industrial Machinery/Components
- Sector
- BGLC Health Care
- CEAD Industrials
- Exchange
- BGLC Nasdaq
- CEAD Nasdaq
- Market Cap
- BGLC 5.8M
- CEAD 6.4M
- IPO Year
- BGLC N/A
- CEAD N/A
- Fundamental
- Price
- BGLC $2.88
- CEAD $8.10
- Analyst Decision
- BGLC
- CEAD
- Analyst Count
- BGLC 0
- CEAD 0
- Target Price
- BGLC N/A
- CEAD N/A
- AVG Volume (30 Days)
- BGLC 1.8M
- CEAD 6.9K
- Earning Date
- BGLC 04-15-2025
- CEAD 05-13-2025
- Dividend Yield
- BGLC N/A
- CEAD N/A
- EPS Growth
- BGLC N/A
- CEAD N/A
- EPS
- BGLC N/A
- CEAD N/A
- Revenue
- BGLC $9,510,646.00
- CEAD $2,803,470.00
- Revenue This Year
- BGLC N/A
- CEAD N/A
- Revenue Next Year
- BGLC N/A
- CEAD N/A
- P/E Ratio
- BGLC N/A
- CEAD N/A
- Revenue Growth
- BGLC N/A
- CEAD N/A
- 52 Week Low
- BGLC $2.01
- CEAD $5.60
- 52 Week High
- BGLC $8.40
- CEAD $12.26
- Technical
- Relative Strength Index (RSI)
- BGLC 51.78
- CEAD 47.34
- Support Level
- BGLC $2.47
- CEAD $7.70
- Resistance Level
- BGLC $2.99
- CEAD $9.00
- Average True Range (ATR)
- BGLC 0.49
- CEAD 0.48
- MACD
- BGLC 0.07
- CEAD -0.03
- Stochastic Oscillator
- BGLC 58.87
- CEAD 30.77
About BGLC BioNexus Gene Lab Corp Common stock
BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.
About CEAD CEA Industries Inc.
CEA Industries Inc through its subsidiary is focused on selling environmental control and other technologies and services to the Controlled Environment Agriculture ("CEA") industry. The company provides integrated mechanical, electrical, and plumbing ("MEP") engineering design, proprietary and curated environmental control equipment, and automation offerings that serve the CEA industry. The Company has one operating segment that is dedicated to the manufacture and sale of its products.